Skip to main content
Fig. 4 | BMC Genomic Data

Fig. 4

From: HYAL3 as a potential novel marker of BLCA patient prognosis

Fig. 4

The correlation between HYAL3 expression and clinical and pathological parameters in bladder cancer (BLCA) patients. The correlation between HYAL3 expression and age (a), OS event (b), TNM stage (c–e), histological grade (f), pathological grade (g), sex (h), subtype (i), or lymphovascular invasion (j)

Back to article page